The interaction of an antimicrobial decapeptide with phospholipid vesicles

被引:25
作者
Choi, MJ
Kang, SH
Kim, S
Chang, JS
Kim, SS
Cho, H
Lee, KH
机构
[1] Inha Univ, Dept Chem, Inchon 402751, South Korea
[2] Charmzone Biomat Res Ctr, Kyeonggi Do, South Korea
[3] Mogam Biotechnol Res Inst, Drug Delivery Res Lab, Kyonggi Do 449910, South Korea
关键词
antibacterial peptide; net charge; permeability lipid membranes; fusion; vesicles;
D O I
10.1016/j.peptides.2004.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Previously, by using combinatorial peptide libraries, we have identified activity-optimized decapeptide (KSL, KKVVFKVKFK-NH2), which exhibited a broad spectrum of the activity against bacteria and fungi without hemolytic activity. In order to examine lipid requirements and to understand the mode of KSL action, we investigated interactions of the peptide with vesicles consisting of various lipid compositions. KSL increased the permeability of negatively charged but not zwitterionic phospholipid membranes, and the leakage was independent on the size of encapsulated molecules (calcein, 1-aminonaphthalene-3,6,8-trisulfonic acid (ANTS)/N,N'-p-xylene bis(pyridinium) bromide (DPX), and fluorescein isothiocyanate (FITC)-dextran with different molecular weight), indicating that the peptide did not form pores or channels in this leakage process. KSL ability to permeabilize vesicles with negatively charged surface was dramatically reduced upon the addition of zwitterionic phospholipid rather than cholesterol, which revealed that the surface charge of lipid membranes played a major role in the activity and selectivity of KSL. Moreover, KSL diastereomer did not increase the permeability of negatively charged vesicles, indicating that the secondary structure of KSL was also required for membrane perturbation activity. Interestingly, KSL had an ability to cause aggregation and subsequent fusion of the acidic vesicles, which seemed to be related to the biological action. Structural studies performed by circular dichroism (CD) spectroscopy indicated that in the presence of acidic vesicles, the P sheet structure of KSL must be required for the ability to (1) induce a leakage of dye from the acidic vesicles (2) to fuse the acidic vesicles. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:675 / 683
页数:9
相关论文
共 32 条
[1]
A novel linear amphipathic β-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids [J].
Blazyk, J ;
Wiegand, R ;
Klein, J ;
Hammer, J ;
Epand, RM ;
Epand, RF ;
Maloy, WL ;
Kari, UP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :27899-27906
[2]
PH-SENSITIVE LIPOSOMES - ACID-INDUCED LIPOSOME FUSION [J].
CONNOR, J ;
YATVIN, MB ;
HUANG, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (06) :1715-1718
[3]
PH-INDUCED DESTABILIZATION OF "PHOSPHATIDYLETHANOLAMINE-CONTAINING LIPOSOMES - ROLE OF BILAYER CONTACT [J].
ELLENS, H ;
BENTZ, J ;
SZOKA, FC .
BIOCHEMISTRY, 1984, 23 (07) :1532-1538
[4]
Epand RM, 2000, BIOPOLYMERS, V55, P358, DOI 10.1002/1097-0282(2000)55:5<358::AID-BIP1009>3.0.CO
[5]
2-8
[6]
Diversity of antimicrobial peptides and their mechanisms of action [J].
Epand, RM ;
Vogel, HJ .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1462 (1-2) :11-28
[7]
SOLID-PHASE PEPTIDE-SYNTHESIS UTILIZING 9-FLUORENYLMETHOXYCARBONYL AMINO-ACIDS [J].
FIELDS, GB ;
NOBLE, RL .
INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1990, 35 (03) :161-214
[8]
DEFENSINS PROMOTE FUSION AND LYSIS OF NEGATIVELY CHARGED MEMBRANES [J].
FUJII, G ;
SELSTED, ME ;
EISENBERG, D .
PROTEIN SCIENCE, 1993, 2 (08) :1301-1312
[9]
CRYSTAL-STRUCTURE OF DEFENSIN HNP-3, AN AMPHIPHILIC DIMER - MECHANISMS OF MEMBRANE PERMEABILIZATION [J].
HILL, CP ;
YEE, J ;
SELSTED, ME ;
EISENBERG, D .
SCIENCE, 1991, 251 (5000) :1481-1485
[10]
Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry [J].
Hong, SY ;
Oh, JE ;
Kwon, MY ;
Choi, MJ ;
Lee, JH ;
Lee, BL ;
Moon, HM ;
Lee, KH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2534-2541